proxyvotesnow.com

Home › Asset managers › ProShares › 2024-2025 › Against the board

ProShares 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal ProShares voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

2,735 proposals.

ProShares, 2024-2025 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedProShares votedFunds
Revolve Group, Inc. June 6, 2025 Election of Directors: Michael Mente Director Elections Board WITHHOLD 10
Rhythm Pharmaceuticals, Inc. September 18, 2024 Election of the Class I directors, each to serve for a three year term until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Stuart A. Arbuckle Director Elections Board WITHHOLD 10
Rhythm Pharmaceuticals, Inc. September 18, 2024 Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan. Compensation Board AGAINST 10
Scholastic Corporation September 18, 2024 Election of Directors: James W. Barge Director Elections Board WITHHOLD 10
The Scotts Miracle-Gro Company January 27, 2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 10
Viridian Therapeutics, Inc. June 20, 2025 To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares. Compensation Board AGAINST 10
Viridian Therapeutics, Inc. June 20, 2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 10
3D Systems Corporation May 16, 2025 The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton Director Elections Board AGAINST 9
3D Systems Corporation May 16, 2025 The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore Director Elections Board AGAINST 9
3D Systems Corporation May 16, 2025 The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson Director Elections Board AGAINST 9
ACM Research, Inc. June 12, 2025 Election of Directors: David H. Wang Director Elections Board WITHHOLD 9
ACM Research, Inc. June 12, 2025 Election of Directors: Tracy Liu Director Elections Board WITHHOLD 9
Acrivon Therapeutics, Inc. June 13, 2025 Election of Class III Directors: Derek DiRocco, Ph.D. Director Elections Board WITHHOLD 9
Acrivon Therapeutics, Inc. June 13, 2025 Election of Class III Directors: Santhosh Palani, Ph.D., C.F.A. Director Elections Board WITHHOLD 9
Adaptive Biotechnologies Corporation June 10, 2025 To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins Director Elections Board WITHHOLD 9
Air Transport Services Group, Inc. February 10, 2025 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger (the "Advisory Compensation Proposal"); and Say-on-Pay Board AGAINST 9
Alector, Inc. June 11, 2025 ELECTION OF DIRECTORS: Paula Hammond, Ph.D. Director Elections Board WITHHOLD 9
Allogene Therapeutics, Inc. June 18, 2025 Election of Directors: Arie Belldegrun, M.D. Director Elections Board WITHHOLD 9
Allogene Therapeutics, Inc. June 18, 2025 Election of Directors: David Chang, M.D., Ph.D. Director Elections Board WITHHOLD 9
Allogene Therapeutics, Inc. June 18, 2025 Election of Directors: Elizabeth Barrett Director Elections Board WITHHOLD 9
Altimmune, Inc. September 26, 2024 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. Say-on-Pay Board AGAINST 9
AppLovin Corporation June 4, 2025 Election of Directors: ADAM FOROUGHI Director Elections Board WITHHOLD 9
AppLovin Corporation June 4, 2025 Election of Directors: ALYSSA HARVEY DAWSON Director Elections Board WITHHOLD 9
AppLovin Corporation June 4, 2025 Election of Directors: BARBARA MESSING Director Elections Board WITHHOLD 9
AppLovin Corporation June 4, 2025 Election of Directors: HERALD CHEN Director Elections Board WITHHOLD 9
AppLovin Corporation June 4, 2025 Election of Directors: MARGARET GEORGIADIS Director Elections Board WITHHOLD 9
Appian Corporation June 4, 2025 Election of Directors: Barbara Bobbie Kilberg Director Elections Board WITHHOLD 9
Appian Corporation June 4, 2025 Election of Directors: Mark Lynch Director Elections Board WITHHOLD 9
Appian Corporation June 4, 2025 Election of Directors: Matthew Calkins Director Elections Board WITHHOLD 9
Appian Corporation June 4, 2025 Election of Directors: Michael Beckley Director Elections Board WITHHOLD 9
Appian Corporation June 4, 2025 Election of Directors: Robert C. Kramer Director Elections Board WITHHOLD 9
Appian Corporation June 4, 2025 Election of Directors: William D. McCarthy Director Elections Board WITHHOLD 9
Applied Therapeutics, Inc. June 9, 2025 Election of Director: Teena Lerner Director Elections Board AGAINST 9
Aquestive Therapeutics, Inc. June 11, 2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 9
Aquestive Therapeutics, Inc. June 11, 2025 To elect Daniel Barber and Timothy E. Morris as Class I members of the Board of Directors, each to serve for a three-year term until the Company's 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified: Daniel Barber Director Elections Board WITHHOLD 9
Aris Water Solutions, Inc. May 21, 2025 Election of Directors: Amanda M. Brock Director Elections Board WITHHOLD 9
Aris Water Solutions, Inc. May 21, 2025 Election of Directors: Jacinto J. Hernandez Director Elections Board WITHHOLD 9
Aris Water Solutions, Inc. May 21, 2025 Election of Directors: W. Howard Keenan, Jr. Director Elections Board WITHHOLD 9
Arista Networks, Inc. May 30, 2025 Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay Board AGAINST 9
Arista Networks, Inc. May 30, 2025 Election of Directors: Daniel Scheinman Director Elections Board WITHHOLD 9
Arista Networks, Inc. May 30, 2025 Election of Directors: Yvonne Wassenaar Director Elections Board WITHHOLD 9
Array Technologies, Inc. May 20, 2025 Advisory vote to approve named executive officer compensation. Say-on-Pay Board AGAINST 9
Array Technologies, Inc. May 20, 2025 ELECTION OF CLASS II DIRECTORS: Jayanthi Iyengar Director Elections Board WITHHOLD 9
Astria Therapeutics, Inc. June 11, 2025 The approval of the first amendment to our Second Amended and Restated 2015 Stock Incentive Plan, to increase the number of shares of our common stock available for grant under the plan by 5,500,000 shares. Compensation Board AGAINST 9
Astria Therapeutics, Inc. June 11, 2025 The approval, by non-binding advisory vote, of our executive compensation. Say-on-Pay Board AGAINST 9
Atea Pharmaceuticals, Inc. June 20, 2025 Election of Class II Directors: Polly Murphy, DVM, PhD Director Elections Board WITHHOLD 9
Aura Biosciences, Inc. June 17, 2025 To elect two Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Elisabet de los Pinos, Ph.D. Director Elections Board WITHHOLD 9
AvePoint, Inc. May 6, 2025 Election of Directors: Janet Schijns Director Elections Board WITHHOLD 9
Biomea Fusion, Inc. June 11, 2025 The election of Bihua Chen, Elizabeth Faust, Ph.D., and Sumita Ray, J.D., as Class I Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2028: Bihua Chen Director Elections Board WITHHOLD 9
Bloom Energy Corp. May 14, 2025 Election of Class I Directors: KR Sridhar Director Elections Board WITHHOLD 9
Bloom Energy Corp. May 14, 2025 Election of Class I Directors: Mary K. Bush Director Elections Board WITHHOLD 9
Bloom Energy Corp. May 14, 2025 To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 9
Braze, Inc. June 26, 2025 Election of Two Class I Directors, each to hold office until our 2028 Annual Meeting of Stockholders: Phillip M. Fernandez Director Elections Board WITHHOLD 9
Brookfield Infrastructure Corporation December 3, 2024 Approve Plan of Arrangement (Reorganization) Extraordinary Transactions Board AGAINST 9
Cartesian Therapeutics, Inc. June 13, 2025 Election of Directors: Timothy C. Barabe, MBA Director Elections Board WITHHOLD 9
Cava Group, Inc. June 20, 2025 Election of Class II Directors: Benjamin Felt Director Elections Board WITHHOLD 9
Cava Group, Inc. June 20, 2025 Election of Class II Directors: Ronald Shaich Director Elections Board WITHHOLD 9
Cava Group, Inc. June 20, 2025 Election of Class II Directors: Theodoros Xenohristos Director Elections Board WITHHOLD 9
CleanSpark, Inc. March 3, 2025 Election of Directors: Dr. Thomas L. Wood Director Elections Board WITHHOLD 9
CleanSpark, Inc. March 3, 2025 To approve, on a non-binding advisory basis, named executive officer compensation Say-on-Pay Board AGAINST 9
Climb Bio, Inc. June 4, 2025 The election of two directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Judith Dunn, Ph.D. Director Elections Board WITHHOLD 9
Codexis, Inc. June 10, 2025 To approve an amendment to the Codexis, Inc. 2019 Incentive Award Plan to increase the number of shares available for issuance thereunder by 8,000,000 shares. Compensation Board AGAINST 9
Codexis, Inc. June 10, 2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 9
Coeur Mining, Inc. May 13, 2025 Election of nine directors: N. Eric Fier Director Elections Board AGAINST 9
Constellium SE May 15, 2025 Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 587,279.54 Capital Structure Board AGAINST 9
Constellium SE May 15, 2025 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Item 15 Capital Structure Board AGAINST 9
Constellium SE May 15, 2025 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 880,919 Capital Structure Board AGAINST 9
Core & Main, Inc. June 24, 2025 Election of Directors: Dennis G. Gipson Director Elections Board WITHHOLD 9
Core Scientific, Inc. May 23, 2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement. Say-on-Pay Board AGAINST 9
Couchbase, Inc. May 29, 2025 Election of Class I Directors: Lynn M. Christensen Director Elections Board WITHHOLD 9
Dick's Sporting Goods, Inc. June 11, 2025 Approval of an amendment to the Company's Certificate of incorporation to Increase the number of authorized shares of Common Stock and Class B Common Stock. Capital Structure Board AGAINST 9
Dick's Sporting Goods, Inc. June 11, 2025 Election of Directors, each for a term that expires in 2026: Anne Fink Director Elections Board WITHHOLD 9
Dick's Sporting Goods, Inc. June 11, 2025 Election of Directors, each for a term that expires in 2026: Larry D. Stone Director Elections Board WITHHOLD 9
Dick's Sporting Goods, Inc. June 11, 2025 Election of Directors, each for a term that expires in 2026: Larry Fitzgerald, Jr. Director Elections Board WITHHOLD 9
Dick's Sporting Goods, Inc. June 11, 2025 Election of Directors, each for a term that expires in 2026: Lawrence J. Schorr Director Elections Board WITHHOLD 9
Dick's Sporting Goods, Inc. June 11, 2025 Election of Directors, each for a term that expires in 2026: Robert W. Eddy Director Elections Board WITHHOLD 9
Dick's Sporting Goods, Inc. June 11, 2025 Election of Directors, each for a term that expires in 2026: William J. Colombo Director Elections Board WITHHOLD 9
Dynatrace, Inc. August 23, 2024 Election of Class II Directors: Jill Ward Director Elections Board WITHHOLD 9
Dynatrace, Inc. August 23, 2024 Election of Class II Directors: Kirsten O. Wolberg Director Elections Board WITHHOLD 9
Editas Medicine, Inc. May 29, 2025 To approve an amendment and restatement of the Company's 2015 Stock Incentive Plan. Compensation Board AGAINST 9
Editas Medicine, Inc. May 29, 2025 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. Say-on-Pay Board AGAINST 9
Enanta Pharmaceuticals, Inc. March 13, 2025 To approve an amendment to our 2019 Equity Incentive Plan. Compensation Board AGAINST 9
Energy Vault Holdings, Inc. May 30, 2025 Election of Class I members of the Board of Directors: Larry Paulson Director Elections Board WITHHOLD 9
Energy Vault Holdings, Inc. May 30, 2025 Election of Class I members of the Board of Directors: Mary Beth Mandanas Director Elections Board WITHHOLD 9
Entrada Therapeutics, Inc. June 11, 2025 Election of Directors: Kush M. Parmar, M.D., Ph.D. Director Elections Board WITHHOLD 9
Essential Utilities, Inc. May 7, 2025 To approve an advisory vote on the compensation paid to the Company's named executive officers for 2024. Say-on-Pay Board AGAINST 9
FARO Technologies, Inc. May 21, 2025 Amendment to the FARO Technologies, Inc. 2022 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,500,000. Compensation Board AGAINST 9
Fastly, Inc. June 11, 2025 To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 9
Fate Therapeutics, Inc. May 29, 2025 To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. Compensation Board AGAINST 9
Foghorn Therapeutics Inc. June 17, 2025 Elect Class II directors each for a three-year term: Adrian Gottschalk Director Elections Board AGAINST 9
Foghorn Therapeutics Inc. June 17, 2025 Elect Class II directors each for a three-year term: Ian F. Smith Director Elections Board AGAINST 9
IonQ, Inc. June 17, 2025 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). Say-on-Pay Board AGAINST 9
Joby Aviation, Inc. June 6, 2025 Election of Directors. To be elected for terms expiring in 2028: Dipender Saluja Director Elections Board WITHHOLD 9
Joby Aviation, Inc. June 6, 2025 Election of Directors. To be elected for terms expiring in 2028: Tetsuo Ogawa Director Elections Board WITHHOLD 9
Johnson Outdoors Inc. February 27, 2025 Election of Directors: John M. Fahey, Jr. Director Elections Board WITHHOLD 9
Johnson Outdoors Inc. February 27, 2025 Election of Directors: Paul G. Alexander Director Elections Board WITHHOLD 9
Kodiak Gas Services, Inc. April 23, 2025 Election of three nominees: Alex N. Darden Director Elections Board WITHHOLD 9
Lamar Advertising Company May 15, 2025 Election of directors: Anna Reilly Director Elections Board WITHHOLD 9
Lamar Advertising Company May 15, 2025 Election of directors: Elizabeth Thompson Director Elections Board WITHHOLD 9
Lamar Advertising Company May 15, 2025 Election of directors: John E. Koerner, III Director Elections Board WITHHOLD 9

← Previous Page 7 of 28 Next →

← Back to ProShares 2024-2025 overview

Built November 7, 2026 from SEC Form N-PX filings.